AntimetabolitesAntineoplastic AgentsAntimetabolites, AntineoplasticFloxuridineTetrahydrouridineTrabeculectomyDrug Screening Assays, AntitumorFluorouracil6-MercaptopurineAntineoplastic Agents, PhytogenicLeukemia L1210Leukemia P388Inosine MonophosphateMethotrexateAmaryllidaceae AlkaloidsPhosphoribosyl PyrophosphateDrug SynergismEllipticinesNarcissusNeoplasmsBibenzylsTumor Cells, CulturedDoxorubicinCell SurvivalMitomycinAntibiotics, AntineoplasticDrug Evaluation, PreclinicalThiadiazinesCytarabineBryostatinsFolic Acid AntagonistsAntineoplastic Agents, AlkylatingCell DivisionPurinesAncitabineGalliumCell CycleDepsipeptidesCisplatinPaclitaxelCell LineApoptosisCell Line, TumorEpothilonesAminoacridinesMolecular StructureDeoxycytidineSarcoma 180KineticsLactonesDaunorubicinDose-Response Relationship, DrugBleomycinEtoposideAntineoplastic Combined Chemotherapy ProtocolsDrug Resistance, NeoplasmProdrugsDrug EvaluationXenograft Model Antitumor AssaysDrug ResistanceMacrolidesNeoplasms, ExperimentalCamptothecinStilbenesEnzyme InhibitorsCell ProliferationMice, NudeHL-60 CellsLung NeoplasmsHistocompatibility Antigens Class IDrug Administration ScheduleVincristineNeoplasm TransplantationIsoquinolinesTime FactorsBiotransformationDrug InteractionsHistocompatibility Antigens Class IIBreast NeoplasmsStereoisomerismDNA DamageCyclophosphamideClinical Trials as TopicLeukemiaOvarian NeoplasmsStructure-Activity RelationshipColonic NeoplasmsDNARNA, MessengerCaspasesTaxoidsCells, CulturedProstatic NeoplasmsPhospholipid EthersReactive Oxygen Species